What We're Reading: FDA Does a Poor Job Tracking Drugs on the Market
What we're reading, January 15, 2016: new report finds flaws in how the FDA tracks drugs after they reach the market; rate of uninsured Hispanic children hits historic low; and CVS and New York State make medication that reverses opioid overdose available without prescription.
What We're Reading: Extending Funding for Medicaid Expansion
What we're reading, January 14, 2016: President Obama proposes extending financial assistance for new states expanding Medicaid eligibility; Hillary Clinton goes hard after Bernie Sanders on single-payer healthcare; and health information exchanges reduce repeated imaging procedures.
What We're Reading: Pharma Executives Brush Off Drug Price Anger
What we're reading, January 13, 2016: at a recent healthcare investor conference pharmaceutical company executives showed no concern over public outrage of rising drug prices; the American Hospital Association urges MedPAC withdraw 340B payment proposal; and California lawmaker reintroduces "right-to-try" bill.
What We're Reading: 43,000 People Lose ACA Tax Credits
What we're reading, January 12, 2016: 43,000 people will lose their Affordable Care Act tax credits for failing to file a 2014 tax return; Kentucky's new governor will dismantle the state's health insurance exchange; and deciding whether to get that medical test.
What We're Reading: Drug Shortages Rise Sharply in EDs
What we're reading, January 11, 2016: drug shortages in the emergency departments have quadrupled since 2008; the government has done little to verify people enrolling after Obamacare deadline under special enrollment categories; and Pfizer increased the prices of 100 drugs.
Claims Follow-Ups May Have Cost Providers Over $3 Billion Says Recondo Survey
A new survey by a healthcare technology solutions company has identified that manual follow-up procedures on late payments from insurance companies costs the organization 33% more per claim than previous estimates.
What We're Reading: Report Reveals Full ACA Enrollment So Far
What we're reading, January 8, 2016: HHS releases report with full Obamacare enrollment information for all 50 states and the District of Columbia; the expansion of the biosimilars in 2016; and promising Ebola treatment found not effective.
What We're Reading: Uninsured Rate in 2015 Essentially Unchanged
What we're reading, January 7, 2016: the uninsured rate at the end of 2015 was essentially unchanged from the beginning of the year; CMS may start paying for some rehab for drug or alcohol addiction; and follow-up care plans after hospital discharge are often too difficult for patients to understand.
What We're Reading: The ACA Fails the Working Poor
What we're reading, January 5, 2016: A special report highlights how the working poor slip through the cracks of the Affordable Care Act; the FDA approved 51 drugs in 2015 with nearly half being first-in-class; and the Senate is expected to vote on President Obama's nomination for FDA commissioner next Tuesday.
What We're Reading: Health Insurers Offer Free Doctor's Visits
What we're reading, January 4, 2016: health insurers offering free doctor's visits for some plans; some consumers find paying the Affordable Care Act penalty cheaper than buying insurance; and clinicians and patients are increasingly worried about opioid dangers.
Penny Mohr Q&A: Comparative Effectiveness Research and Healthcare Disparities
Penny Mohr, MA, senior program officer for improving healthcare systems at the Patient-Centered Outcomes Research Institute, discusses comparative effectiveness research, healthcare disparities, and patient-centered care at the 20th annual international meeting of ISPOR.
What We're Reading: Small Innovations Make a Big Difference
What we're reading, December 31, 2015: small innovations from doctors and insurers can make a big difference in cutting healthcare costs; WellCare is transitioning its pharmacy benefit management to CVS Health; and US health officials remind Americans to get the flu shot.
What We're Reading: Generic Drug Prices Declined in 2015
What we're reading, December 30, 2015: most commonly used generic drugs were cheaper at the end of 2015, meanwhile the FDA has a huge backlog of generic drug applications, and few states are expected to expand Medicaid in 2016.
What We're Reading: Medicaid Enrollees Demand Hepatitis C Treatment
What we're reading, December 28, 2015: patients fight for Medicaid coverage of expensive hepatitis C treatment, Express Scripts develops programs to protect insurer's from pricey new drugs, and Republicans divided over Medicaid expansion.
Q&A on Patient Engagement With Dr Emil Chiauzzi of PatientsLikeMe
Emil Chiauzzi, PhD, research director, client services at PatientsLikeMe, sat down for an interview at the ISPOR 20th Annual International Meeting to discuss using social media for patient engagement and improving the relationships between researchers and patients.
What We're Reading: Free Drug Could Get Costly
What we're reading, December 25, 2015: a drug that is currently free could get very costly; this year's flu season is expected to be mild; and before they went on recess, members of Congress introduced a number of healthcare-related bills.
What We're Reading: Co-Op Failures Could Have Been Avoided
What we're reading, December 24, 2015: more than half of Affordable Care Act co-ops will be closed by the end of 2015, but this could have been avoided; 5 senators are pressing CMS for information on containing drug costs; and a task force does not recommend screening all teens and children for high cholesterol.
What We're Reading: Most Expensive Medicare Drugs
What we're reading, December 23, 2015: CMS releases data on the most expensive Medicare drugs, while HHS reports strong enrollment numbers on HealthCare.gov, and Hillary Clinton outlines a plan to spend $20 billion on Alzheimer's disease research.
NPC's Michael Ciarametaro Discusses the Move to Bundled Payments
As the healthcare system moves to an environment of value-based payment, bundled payments could become the next step in healthcare transformation. However, there are both opportunities and risks in this form of value-based payment, explained Michael Ciarametaro, MBA, director of research at the National Pharmaceutical Council, at the ISPOR 20th Annual International Meeting.
What We're Reading: US Task Force Releases Statin Use Recommendations
What we're reading, December 22, 2015: experts recommend using statins in adults between the ages of 40 years and 75 years; Republicans and Democrats are equally concerned about rising healthcare costs; and Martin Shkreli now fired as CEO of a second company.